As microbial products advance toward later clinical phases and commercialization, process requirements become more complex. What worked during early development may require further optimization to ensure consistent performance, scalability, and manufacturing readiness.
This article explores how structured process reviews and technology transfer activities can uncover hidden risks, strengthen process understanding, and improve robustness before validation and commercial production. Drawing on real-world examples, it highlights opportunities to enhance reproducibility, efficiency, and long-term manufacturing success.
Learn how a multidisciplinary approach can help future-proof your microbial manufacturing process and support a smoother path to commercial supply.
